Online citations, reference lists, and bibliographies.
← Back to Search

Alcoholic Liver Disease: Mechanisms Of Injury And Targeted Treatment

A. Louvet, P. Mathurin
Published 2015 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Alcoholic liver disease (ALD) is a complex process that includes a wide spectrum of hepatic lesions, from steatosis to cirrhosis. Cell injury, inflammation, oxidative stress, regeneration and bacterial translocation are key drivers of alcohol-induced liver injury. Alcoholic hepatitis is the most severe form of all the alcohol-induced liver lesions. Animal models of ALD mainly involve mild liver damage (that is, steatosis and moderate inflammation), whereas severe alcoholic hepatitis in humans occurs in the setting of cirrhosis and is associated with severe liver failure. For this reason, translational studies using humans and human samples are crucial for the development of new therapeutic strategies. Although multiple attempts have been made to improve patient outcome, the treatment of alcoholic hepatitis is still based on abstinence from alcohol and brief exposure to corticosteroids. However, nearly 40% of patients with the most severe forms of alcoholic hepatitis will not benefit from treatment. We suggest that future clinical trials need to focus on end points other than mortality. This Review discusses the main pathways associated with the progression of liver disease, as well as potential therapeutic strategies targeting these pathways.
This paper references
10.1152/ajpgi.1999.277.6.G1240
Iron primes hepatic macrophages for NF-kappaB activation in alcoholic liver injury.
H. Tsukamoto (1999)
10.1172/JCI114008
Effects of chronic ethanol feeding on rat hepatocytic glutathione. Relationship of cytosolic glutathione to efflux and mitochondrial sequestration.
J. C. Fernández-Checa (1989)
10.1111/j.1440-1746.2006.04582.x
Alcohol and lipid metabolism
D. Crabb (2006)
10.1016/j.jhep.2010.01.029
Harmful effect of adipose tissue on liver lesions in patients with alcoholic liver disease.
S. Naveau (2010)
10.1053/j.gastro.2010.01.040
Pentoxifylline does not decrease short-term mortality but does reduce complications in patients with advanced cirrhosis.
D. Lebrec (2010)
10.1097/01.ALC.0000189288.30358.4B
Oxidative stress and signal transduction pathways in alcoholic liver disease.
T. Zima (2005)
10.1074/jbc.M202411200
Ethanol Induces Fatty Acid Synthesis Pathways by Activation of Sterol Regulatory Element-binding Protein (SREBP)*
M. You (2002)
10.1002/HEP.510260621
Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat
Y. Iimuro (1997)
10.1152/ajpcell.00328.2007
H9c2 cardiomyoblasts produce thyroid hormone.
C. Meischl (2008)
10.3748/WJG.15.1613
Pentoxifylline versus prednisolone for severe alcoholic hepatitis: a randomized controlled trial.
B. De (2009)
10.1002/9781119515777.ch37
[Alcoholic liver disease].
S. Kato (1995)
10.1111/J.1530-0277.2002.TB02707.X
Long-term ethanol feeding enhances susceptibility of the liver to orally administered lipopolysaccharides in rats.
H. Tamai (2002)
10.1074/JBC.M105352200
Overexpression of Manganese Superoxide Dismutase Prevents Alcohol-induced Liver Injury in the Rat*
M. Wheeler (2001)
10.1016/j.biocel.2009.09.014
Liver regeneration: alternative epithelial pathways.
G. Michalopoulos (2011)
10.1002/hep.27489
Dysbiosis‐induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice
P. Chen (2015)
10.1074/JBC.M302140200
Peroxisome Proliferator-activated Receptor α (PPARα) Agonist Treatment Reverses PPARα Dysfunction and Abnormalities in Hepatic Lipid Metabolism in Ethanol-fed Mice*
M. Fischer (2003)
10.1074/JBC.M008791200
The transcriptional and DNA binding activity of peroxisome proliferator-activated receptor alpha is inhibited by ethanol metabolism. A novel mechanism for the development of ethanol-induced fatty liver.
A. Galli (2001)
10.1016/j.jhep.2014.05.014
Pentoxifylline vs. corticosteroid to treat severe alcoholic hepatitis: a randomised, non-inferiority, open trial.
Seung Ha Park (2014)
10.1053/JHEP.2001.25350
Toll‐like receptor 4 is involved in the mechanism of early alcohol‐induced liver injury in mice
T. Uesugi (2001)
10.1053/j.gastro.2007.01.053
Differential contributions of C3, C5, and decay-accelerating factor to ethanol-induced fatty liver in mice.
M. T. Pritchard (2007)
10.1053/j.gastro.2011.09.002
Alcoholic liver disease: pathogenesis and new therapeutic targets.
B. Gao (2011)
10.1016/S0741-8329(02)00230-6
S-Adenosyl-L-methionine and alcoholic liver disease in animal models: implications for early intervention in human beings.
C. Lieber (2002)
10.1053/j.gastro.2010.04.041
Complement and alcoholic liver disease: role of C1q in the pathogenesis of ethanol-induced liver injury in mice.
J. I. Cohen (2010)
10.1152/AJPGI.00537.2004
Exposure to bacterial cell wall products triggers an inflammatory phenotype in hepatic stellate cells.
P. Brun (2005)
10.1001/jama.2013.276300
Prednisolone with vs without pentoxifylline and survival of patients with severe alcoholic hepatitis: a randomized clinical trial.
P. Mathurin (2013)
- induced liver injury : a pilot study
N. M. Delzenne (2008)
10.1002/hep.25641
Interstrain differences in liver injury and one‐carbon metabolism in alcohol‐fed mice
Masato Tsuchiya (2012)
10.4049/jimmunol.176.12.7628
TLR2- and TLR4-Mediated Signals Determine Attenuation or Augmentation of Inflammation by Acute Alcohol in Monocytes1
S. Oak (2006)
10.1016/0270-9139(94)90430-8
Effect of S-adenosyl-L-methionine (SAMe) on glutathione and functional integrity of mitochondria in periportal and perivenous hepatocytes from chronic ethanol-fed rats
C. Garcia-Ruiz (1994)
10.1007/BF02235538
Natural history of alcoholic hepatitis
M. Lischner (2005)
Pentoxifylline suppression of tumor necrosis factor gene transcription.
G. Doherty (1991)
10.1053/j.gastro.2008.02.022
Accumulation of hedgehog-responsive progenitors parallels alcoholic liver disease severity in mice and humans.
Youngmi Jung (2008)
10.1152/ajpgi.90327.2008
Hepatic macrophage iron aggravates experimental alcoholic steatohepatitis.
S. Xiong (2008)
10.1002/hep.22074
Inhibition of adiponectin production by homocysteine: A potential mechanism for alcoholic liver disease
Zhenyuan Song (2008)
10.1016/j.jhep.2012.04.004
EASL clinical practical guidelines: management of alcoholic liver disease.
P. Mathurin (2012)
10.1002/hep.22470
The critical role of toll‐like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88
I. Hritz (2008)
10.1084/JEM.172.1.391
Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway
J. Han (1990)
10.1053/j.gastro.2014.01.018
A histologic scoring system for prognosis of patients with alcoholic hepatitis.
J. Altamirano (2014)
10.1172/JCI13505
Role of AMP-activated protein kinase in mechanism of metformin action.
G. Zhou (2001)
10.1172/JCI118077
Experimental liver cirrhosis induced by alcohol and iron.
H. Tsukamoto (1995)
10.1016/j.jhep.2007.10.010
Early switch to pentoxifylline in patients with severe alcoholic hepatitis is inefficient in non-responders to corticosteroids.
A. Louvet (2008)
10.7326/0003-4819-113-4-299
Do corticosteroids reduce mortality from alcoholic hepatitis? A meta-analysis of the randomized trials.
T. Imperiale (1990)
10.1002/hep.24599
An essential role for monocyte chemoattractant protein‐1 in alcoholic liver injury: Regulation of proinflammatory cytokines and hepatic steatosis in mice
P. Mandrekar (2011)
10.1074/jbc.M101632200
Chronic Ethanol Exposure Potentiates Lipopolysaccharide Liver Injury Despite Inhibiting Jun N-terminal Kinase and Caspase 3 Activation*
A. Koteish (2002)
10.1016/J.JHEP.2007.03.027
A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis.
S. Stewart (2007)
10.1016/j.jhep.2012.09.016
Activation of toll-like receptor 3 attenuates alcoholic liver injury by stimulating Kupffer cells and stellate cells to produce interleukin-10 in mice.
Jin-Seok Byun (2013)
10.1016/S0168-8278(01)00289-6
Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH.
P. Mathurin (2002)
10.1152/AJPCELL.00102.2004
Gastroduodenal mucus bicarbonate barrier: protection against acid and pepsin.
A. Allen (2005)
10.1016/S0168-8278(00)80219-6
Blood neutrophil functions and cytokine release in severe alcoholic hepatitis: effect of corticosteroids.
J. Taïeb (2000)
10.1146/ANNUREV.NUTR.20.1.395
ALCOHOL: its metabolism and interaction with nutrients.
C. Lieber (2000)
10.1002/hep.27447
Liver is the major source of elevated serum lipocalin‐2 levels after bacterial infection or partial hepatectomy: A critical role for IL‐6/STAT3
M. Xu (2015)
10.1016/J.BIOCHI.2007.09.019
Ethanol consumption impairs regulation of fatty acid metabolism by decreasing the activity of AMP-activated protein kinase in rat liver.
Javier García-Villafranca (2008)
10.1111/j.1360-0443.2009.02521.x
Alcohol-related cirrhosis--early abstinence is a key factor in prognosis, even in the most severe cases.
C. Verrill (2009)
10.1038/nm788
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase
T. Yamauchi (2002)
10.1002/hep.26419
Chronic plus binge ethanol feeding synergistically induces neutrophil infiltration and liver injury in mice: A critical role for E‐selectin
Adeline Bertola (2013)
10.1002/hep.21138
Differential liver sensitization to Toll‐like receptor pathways in mice with alcoholic fatty liver
T. Gustot (2006)
10.1002/HEP.510260323
Transport of reduced glutathione in hepatic mitochondria and mitoplasts from ethanol‐treated rats: Effect of membrane physical properties and S‐adenosyl‐L‐methionine
A. Colell (1997)
10.1053/JHEP.2000.19621
Exacerbation of alcoholic liver injury by enteral endotoxin in rats
P. Mathurin (2000)
10.1186/1471-230X-13-55
White cell count and platelet count associate with histological alcoholic hepatitis in jaundiced harmful drinkers
T. Hardy (2013)
10.1016/j.jhep.2011.02.021
The role of liver biopsy in the diagnosis and prognosis of patients with acute deterioration of alcoholic cirrhosis.
R. Mookerjee (2011)
10.1111/j.1365-2036.2007.03302.x
Fibrosis progression occurs in a subgroup of heavy drinkers with typical histological features
P. Mathurin (2007)
10.1016/j.jhep.2010.11.005
Endoplasmic reticulum stress in liver disease.
H. Malhi (2011)
Anti - tumor necrosis factor alpha treatment promotes apoptosis and prevents liver regeneration in a transgenic mouse model of chronic hepatitis C
E. Brenndorfer (2008)
10.1111/j.1572-0241.2008.02104.x
A New Scoring System for Prognostic Stratification of Patients With Alcoholic Hepatitis
M. Domínguez (2008)
Iron activates NF-kappaB in Kupffer cells.
H. She (2002)
10.1016/S0168-8278(02)00442-7
Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis.
H. Tilg (2003)
10.1016/S0016-5085(99)70354-9
Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice.
M. Yin (1999)
10.1055/S-2007-1007172
Mitochondrial glutathione: importance and transport.
J. Fernández-Checa (1998)
10.1002/hep.21607
The Lille model: A new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids
A. Louvet (2007)
10.1056/NEJMc1308785
Oncofetal gene SALL4 in aggressive hepatocellular carcinoma.
Kol Jia Yong (2013)
10.1136/gut.52.8.1182
Tumour necrosis factor α is an important mediator of portal and systemic haemodynamic derangements in alcoholic hepatitis
R. Mookerjee (2003)
Steroids or Pentoxifylline for Alcoholic Hepatitis: Results of the STOPAH Trial
M Thursz (2014)
10.1152/AJPGI.00542.2004
Chronic ethanol feeding and folate deficiency activate hepatic endoplasmic reticulum stress pathway in micropigs.
Farah Esfandiari (2005)
10.1111/j.1440-1746.2007.05276.x
Dissection of endoplasmic reticulum stress signaling in alcoholic and non‐alcoholic liver injury
Cheng Ji (2008)
10.1002/hep.27211
Long‐term outcome in patients with severe alcoholic hepatitis can be reliably determined using an in vitro measure of steroid sensitivity
A. Dhanda (2015)
10.1002/HEP.510280509
Tumor necrosis factor primes hepatocytes for DNA replication in the rat
E. M. Webber (1998)
10.1152/ajpgi.00041.2014
Animals models of gastrointestinal and liver diseases. Animal models of alcohol-induced liver disease: pathophysiology, translational relevance, and challenges.
S. Mathews (2014)
10.1002/hep.20399
Peroxisome proliferator-activated receptor alpha protects against alcohol-induced liver damage.
T. Nakajima (2004)
10.1007/BF02233094
Anabolic steroid therapy as an adjunct to diet in alcoholic hepatic steatosis
C. Mendenhall (2005)
10.1053/j.gastro.2014.07.018
Cell death and cell death responses in liver disease: mechanisms and clinical relevance.
T. Luedde (2014)
10.1053/j.gastro.2014.01.020
Interactions between the intestinal microbiome and liver diseases.
B. Schnabl (2014)
10.1172/JCI105200
EFFECTS OF PROLONGED ETHANOL INTAKE: PRODUCTION OF FATTY LIVER DESPITE ADEQUATE DIETS.
C. Lieber (1965)
10.1152/AJPGI.00108.2002
Iron activates NF-κB in Kupffer cells
H. She (2002)
10.1002/hep.26521
Human and experimental evidence supporting a role for osteopontin in alcoholic hepatitis
O. Morales-Ibanez (2013)
10.1002/HEP.1840400428
Peroxisome proliferator‐activated receptor α protects against alcohol‐induced liver damage
Tamie Nakajima (2004)
10.1016/J.HEP.2003.09.038
Early change in bilirubin levels is an important prognostic factor in severe alcoholic hepatitis treated with prednisolone
P. Mathurin (2003)
10.1016/j.jhep.2012.03.024
Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD).
W. Dunn (2012)
10.1016/S0898-6568(00)00149-2
LPS induction of gene expression in human monocytes.
M. Guha (2001)
10.1053/j.gastro.2008.08.057
A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis.
Nicholas C. Boetticher (2008)
10.1007/s11095-008-9571-x
Discovery and Development of Toll-Like Receptor 4 (TLR4) Antagonists: A New Paradigm for Treating Sepsis and Other Diseases
C. Leon (2008)
10.1111/j.1440-1746.2006.04595.x
Cytochrome P450 2E1‐dependent oxidant stress and upregulation of anti‐oxidant defense in liver cells
A. Cederbaum (2006)
10.1002/jcp.20366
Normal rat hepatic stellate cells respond to endotoxin in LBP‐independent manner to produce inhibitor(s) of DNA synthesis in hepatocytes
C. Thirunavukkarasu (2005)
10.1053/j.gastro.2009.01.056
Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis.
M. Domínguez (2009)
10.1053/JHEP.2002.31782
Risk factors of fibrosis in alcohol‐induced liver disease
B. Raynard (2002)
10.1002/hep.23870
Anti–tumor necrosis factor α treatment promotes apoptosis and prevents liver regeneration in a transgenic mouse model of chronic hepatitis C
E. Brenndörfer (2010)
10.1136/gut.2004.050781
Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score
E. Forrest (2005)
10.1152/ajpgi.1999.277.6.G1240
Iron primes hepatic macrophages for NF-κB activation in alcoholic liver injury.
H. Tsukamoto (1999)
10.1016/j.jhep.2012.06.018
Stress management: How the unfolded protein response impacts fatty liver disease.
Dru Imrie (2012)
10.1016/j.jhep.2008.02.015
Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis.
V. Stadlbauer (2008)
10.1074/JBC.M212076200
Up-regulation of CD14 in Liver Caused by Acute Ethanol Involves Oxidant-dependent AP-1 Pathway*
M. Wheeler (2003)
10.1016/S0399-8320(04)95026-9
Combination of steroids with infliximab or placebo in severe alcoholic hepatitis : a randomized controlled pilot study
S. Naveau (2004)
10.1111/J.1530-0277.2000.TB00012.X
Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance.
M. Fujimoto (2000)
10.1002/hep.20821
Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice
M. You (2005)
10.1002/hep.21880
Glucocorticoid‐induced leucine zipper: A key protein in the sensitization of monocytes to lipopolysaccharide in alcoholic hepatitis
Haifa Hamdi (2007)
10.1111/j.1530-0277.2009.01022.x
Intestinal dysbiosis: a possible mechanism of alcohol-induced endotoxemia and alcoholic steatohepatitis in rats.
E. Mutlu (2009)
TNF-α induces hepatic steatosis in mice by enhancing gene expression of sterol regulatory element binding protein-1c (SREBP-1c)
遠藤 美月 (2008)
10.1111/J.1530-0277.2007.00452.X
Chronic ethanol-induced insulin resistance is associated with macrophage infiltration into adipose tissue and altered expression of adipocytokines.
L. Kang (2007)
Peroxisome proliferatoractivated receptor alpha protects against alcohol-induced liver damage
T Nakajima (2004)
10.1016/S0891-5849(01)00748-1
The role of Kupffer cell oxidant production in early ethanol-induced liver disease.
M. Wheeler (2001)
10.1053/J.GASTRO.2004.01.022
Activated natural killer T cells induce liver injury by Fas and tumor necrosis factor-alpha during alcohol consumption.
M. Minagawa (2004)
10.1016/J.ALCOHOL.2004.07.008
Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis.
C. Lieber (2004)
10.1172/JCI115010
Impaired uptake of glutathione by hepatic mitochondria from chronic ethanol-fed rats. Tracer kinetic studies in vitro and in vivo and susceptibility to oxidant stress.
J. C. Fernández-Checa (1991)
10.1136/gutjnl-2011-301146
Transcriptome analysis identifies TNF superfamily receptors as potential therapeutic targets in alcoholic hepatitis
Silvia Affò (2012)
10.1152/ajpgi.00380.2011
Colonic microbiome is altered in alcoholism.
E. Mutlu (2012)
Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease
J Wan (2014)
10.1038/nature13568
Alterations of the human gut microbiome in liver cirrhosis
N. Qin (2014)
10.1016/S0002-9440(10)63489-X
Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease.
T. Roskams (2003)
10.1172/JCI17797
The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice.
A. Xu (2003)
10.1016/J.JHEP.2005.11.039
Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis--a randomised clinical trial.
Martin Phillips (2006)
10.1002/hep.26607
M2 Kupffer cells promote M1 Kupffer cell apoptosis: A protective mechanism against alcoholic and nonalcoholic fatty liver disease
Jinghong Wan (2014)
10.1111/j.1440-1746.2007.05277.x
Oxidative stress in alcoholic liver disease: Role of NADPH oxidase complex
S. de Minicis (2008)
10.1016/S0016-5085(19)33180-4
Natural history of alcoholic hepatitis. 3. Histological changes.
J. Galambos (1972)
10.1136/gut.2010.224097
Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data
P. Mathurin (2010)
10.1016/J.YSUR.2011.03.010
Enteral nutrition with or without N-acetylcysteine in the treatment of severe acute alcoholic hepatitis: A randomized multicenter controlled trial
J. Daly (2011)
10.1002/HEP.1840100417
Experimental methods of ethanol administration
C. Lieber (1989)
10.1152/AJPREGU.1984.247.3.R595
Long-term cannulation model for blood sampling and intragastric infusion in the rat.
H. Tsukamoto (1984)
10.1002/hep.24018
Enteric dysbiosis associated with a mouse model of alcoholic liver disease
Arthur W. Yan (2011)
10.3748/wjg.v20.i44.16639
Gut microbiota in alcoholic liver disease: pathogenetic role and therapeutic perspectives.
G. Malaguarnera (2014)
10.1111/j.1530-0277.2012.01742.x
Autophagy in alcohol-induced liver diseases.
A. Dolganiuc (2012)
10.1136/gutjnl-2014-308410
Progenitor cell expansion and impaired hepatocyte regeneration in explanted livers from alcoholic hepatitis
L. Dubuquoy (2015)
10.1016/0016-5085(95)90027-6
Antibiotics prevent liver injury in rats following long-term exposure to ethanol.
Y. Adachi (1995)
10.1152/AJPCELL.00559.2003
Cell mechanics and mechanotransduction: pathways, probes, and physiology.
H. Huang (2004)
10.1016/J.JHEP.2004.04.028
Soluble TNF-R1, but not tumor necrosis factor alpha, predicts the 3-month mortality in patients with alcoholic hepatitis.
L. Spahr (2004)
10.1016/J.FREERADBIOMED.2003.10.017
Heme oxygenase-1 protects HepG2 cells against cytochrome P450 2E1-dependent toxicity.
P. Gong (2004)
10.1152/AJPGI.1997.272.6.G1355
Role of iron in NF-kappa B activation and cytokine gene expression by rat hepatic macrophages.
M. Lin (1997)
10.1038/nrendo.2011.126
Targeting gut microbiota in obesity: effects of prebiotics and probiotics
N. Delzenne (2011)
10.1093/ALCALC/33.6.606
Presence of plasma endotoxin is correlated with tumour necrosis factor receptor levels and disease activity in alcoholic cirrhosis.
C. Hanck (1998)
10.1002/hep.23666
Theophylline improves steroid sensitivity in acute alcoholic hepatitis
S. Kendrick (2010)
10.1002/hep.20309
Role of TNF‐α in ethanol‐induced hyperhomocysteinemia and murine alcoholic liver injury
Cheng Ji (2004)
10.1002/HEP.510250120
Excess weight risk factor for alcoholic liver disease
S. Naveau (1997)
10.1053/GAST.2000.20189
Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial.
E. Akriviadis (2000)
10.1053/J.GASTRO.2003.12.008
Pioglitazone prevents alcohol-induced fatty liver in rats through up-regulation of c-Met.
K. Tomita (2004)
10.1016/J.FREERADBIOMED.2007.11.004
CYP2E1 and oxidative liver injury by alcohol.
Y. Lu (2008)
10.1111/j.1530-0277.2012.01852.x
Chronic ethanol feeding alters miRNA expression dynamics during liver regeneration.
Rachael P Dippold (2013)
10.1016/j.jhep.2013.02.016
Endoplasmic reticulum stress induces fibrogenic activity in hepatic stellate cells through autophagy.
V. Hernández-Gea (2013)
10.1002/hep.20206
A double‐blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis
S. Naveau (2004)
10.1002/hep.25614
Liver progenitor cell markers correlate with liver damage and predict short‐term mortality in patients with alcoholic hepatitis
P. Sancho-Bru (2012)
10.1002/hep.23572
Acetate, the key modulator of inflammatory responses in acute alcoholic hepatitis
S. Kendrick (2010)
10.1016/j.jhep.2008.10.024
Infliximab monotherapy for severe alcoholic hepatitis and predictors of survival: an open label trial.
P. Sharma (2009)
10.1002/(SICI)1096-9896(199809)186:1<82::AID-PATH151>3.0.CO;2-D
Distinct patterns of chemokine expression are associated with leukocyte recruitment in alcoholic hepatitis and alcoholic cirrhosis
S. Afford (1998)
10.1016/S0168-8278(00)80242-1
Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease.
A. Parlesak (2000)
10.1152/ajpgi.00575.2007
Involvement of mammalian sirtuin 1 in the action of ethanol in the liver.
M. You (2008)
10.3181/00379727-205-43703
Lactobacillus Feeding Reduces Endotoxemia and Severity of Experimental Alcoholic Liver (Disease)
A. Nanji (1994)
10.1016/S0168-8278(98)80227-4
Plasma levels of soluble tumor necrosis factor receptors p55 and p75 in patients with alcoholic liver disease of increasing severity.
S. Naveau (1998)
10.1016/j.cld.2012.08.002
Alcohol metabolism.
A. Cederbaum (2012)
10.1053/j.gastro.2009.04.062
Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor.
A. Louvet (2009)
10.1016/j.jhep.2013.03.033
Decoding cell death signals in liver inflammation.
C. Brenner (2013)
10.1034/j.1600-0676.2003.01804.x
Five‐year survival predictive factors in patients with excessive alcohol intake and cirrhosis. Effect of alcoholic hepatitis, smoking and abstinence
F. Pessione (2003)
10.1002/HEP.1840160619
Hepatic mitochondrial glutathione depletion and progression of experimental alcoholic liver disease in rats
Akeshi Hirano (1992)
10.1056/NEJMoa1101214
Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis.
E. Nguyen-Khac (2011)
10.1053/J.GASTRO.2006.12.036
Hepatic expression of candidate genes in patients with alcoholic hepatitis: correlation with disease severity.
J. Colmenero (2007)
10.1152/ajpendo.90412.2008
Alcohol--intoxicating roadblocks and bottlenecks in hepatic protein and lipid metabolism.
P. Molina (2008)
10.1016/j.alcohol.2008.12.009
Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis.
C. Forsyth (2009)
10.1152/ajpcell.00168.2013
Reduced GM1 ganglioside in CFTR-deficient human airway cells results in decreased β1-integrin signaling and delayed wound repair.
Yutaka Itokazu (2014)
10.1111/J.1530-0277.1999.TB04217.X
Microsomal ethanol-oxidizing system (MEOS): the first 30 years (1968-1998)--a review.
C. Lieber (1999)
10.1016/j.cmet.2007.12.007
Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver.
W. Jeong (2008)
10.1002/hep.23430
Interplay of hepatic and myeloid signal transducer and activator of transcription 3 in facilitating liver regeneration via tempering innate immunity
H. Wang (2010)
10.1002/hep.26538
Loss of caspase‐8 in hepatocytes accelerates the onset of liver regeneration in mice through premature nuclear factor kappa B activation
Julia Freimuth (2013)
10.1074/JBC.273.9.5053
Tumor Necrosis Factor-α Stimulates the Maturation of Sterol Regulatory Element Binding Protein-1 in Human Hepatocytes through the Action of Neutral Sphingomyelinase*
J. F. Lawler (1998)
10.1002/hep.22335
An inducible autocrine cascade regulates rat hepatocyte proliferation and apoptosis responses to tumor necrosis factor‐α
Benjamin D. Cosgrove (2008)
10.1002/hep.24159
In vitro steroid resistance correlates with outcome in severe alcoholic hepatitis
A. Di Mambro (2011)
10.1152/ajpcell.00001.2012
From stress specificity to basal necessity: ATF6 uprising. Focus on "Pancreatic β-cells depend on basal expression of active ATF6α-p50 for cell survival even under nonstress conditions".
Eric Chevet (2012)
10.1016/j.alcohol.2008.08.006
Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study.
I. Kirpich (2008)
corticosteroids reduce mortality from alcoholic hepatitis ? A meta - analysis of the randomized trials
W. Maddrey (1990)
10.1002/HEP.510240529
Chemokine levels in human liver homogenates: Associations between GRO α and histopathological evidence of alcoholic hepatitis
J. Maltby (1996)
10.1016/0016-5085(78)90401-8
Corticosteroid therapy of alcoholic hepatitis
Willis C. Maddrey (1978)
The role of liver biopsy in the diagnosis and prognosis of patients with acute deterioration of alcoholic cirrhosis
Mookerjee (2011)
10.1002/PATH.1711520107
Endotoxin induced hepatic necrosis in rats on an alcohol diet
B. Bhagwandeen (1987)
10.1016/J.JHEP.2004.10.019
Patients with acute on chronic liver failure display "sepsis-like" immune paralysis.
H. Wasmuth (2005)
10.1152/ajpgi.00050.2008
Contribution of the sympathetic hormone epinephrine to the sensitizing effect of ethanol on LPS-induced liver damage in mice.
Claudia von Montfort (2008)
10.1016/S0168-8278(86)80006-X
Histological course of alcoholic hepatitis. Influence of abstinence, sex and extent of hepatic damage.
A. Parés (1986)
10.1053/j.gastro.2013.11.008
Deletion of SIRT1 from hepatocytes in mice disrupts lipin-1 signaling and aggravates alcoholic fatty liver.
Huquan Yin (2014)
10.1152/AJPGI.00376.2004
Recent events in alcoholic liver disease V. effects of ethanol on liver regeneration.
A. Diehl (2005)
10.1002/hep.24524
Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating Kupffer cell polarization in mice
A. Louvet (2011)
10.1002/hep.26169
Macrophage migration inhibitory factor contributes to ethanol‐induced liver injury by mediating cell injury, steatohepatitis, and steatosis
Mark A. Barnes (2013)
10.1002/hep.23264
Severe sepsis in cirrhosis
T. Gustot (2009)
10.1136/gutjnl-2013-306098
CCL20 mediates lipopolysaccharide induced liver injury and is a potential driver of inflammation and fibrosis in alcoholic hepatitis
Silvia Affò (2014)
10.1053/j.gastro.2014.09.014
Supplementation of saturated long-chain fatty acids maintains intestinal eubiosis and reduces ethanol-induced liver injury in mice.
P. Chen (2015)
10.3748/WJG.V13.I35.4746
Role of iron in hepatic fibrosis: one piece in the puzzle.
Marie-A Philippe (2007)
10.1016/J.JHEP.2006.11.020
Hepatic gene expression and lipid parameters in complement C3(-/-) mice that do not develop ethanol-induced steatosis.
I. Bykov (2007)
Recent Advances in Alcoholic Liver Disease
M. You (2004)
10.1016/0741-8329(93)90067-X
Mitochondrial glutathione depletion in alcoholic liver disease.
J. Fernández-Checa (1993)
Peroxisome proliferator-activated receptor alpha (PPARalpha) agonist treatment reverses PPARalpha dysfunction and abnormalities in hepatic lipid metabolism in ethanol-fed mice.
M. Fischer (2003)
10.1016/S0016-5085(03)00276-2
Betaine decreases hyperhomocysteinemia, endoplasmic reticulum stress, and liver injury in alcohol-fed mice.
Cheng Ji (2003)
10.1111/j.1530-0277.2008.00842.x
A recent perspective on alcohol, immunity, and host defense.
G. Szabo (2009)
10.2165/00003088-200342010-00001
Role of Variability in Explaining Ethanol Pharmacokinetics
Å. Norberg (2003)
10.1053/JHEP.2003.50182
Toll‐Like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells
Yong-Han Paik (2003)
10.1007/s10620-012-2097-4
Corticosteroid Plus Pentoxifylline Is Not Better than Corticosteroid Alone for Improving Survival in Severe Alcoholic Hepatitis (COPE Trial)
S. Sidhu (2012)
10.1002/HEP.1840050212
Severe and progressive steatosis and focal necrosis in rat liver induced by continuous intragastric infusion of ethanol and low fat diet
H. Tsukamoto (1985)



This paper is referenced by
10.1038/s41422-019-0175-2
Complement C3 activation regulates the production of tRNA-derived fragments Gly-tRFs and promotes alcohol-induced liver injury and steatosis
F. Zhong (2019)
10.1007/s10620-016-4254-7
Targeting Hepatic Fibrosis in Autoimmune Hepatitis
A. Montano-Loza (2016)
10.1002/ctm2.112
Modulation of gut microbiota mediates berberine‐induced expansion of immuno‐suppressive cells to against alcoholic liver disease
Sha Li (2020)
10.1586/17474124.2015.1069705
Host homeostatic responses to alcohol-induced cellular stress in animal models of alcoholic liver disease
H. J. Wang (2015)
10.1007/s11538-017-0336-8
A Systems Biology Approach to Understanding Alcoholic Liver Disease Molecular Mechanism: The Development of Static and Dynamic Models
Leila Shafaghati (2017)
10.1016/j.clinre.2017.06.001
Circulating levels of bacterial DNA and risk of infections in severe alcoholic hepatitis.
Alexandre Louvet (2017)
10.4236/FNS.2017.812083
Ascorbic Acid Attenuates Acute Ethanol-Induced Liver Injury in SMP30 Knockout Mice
Eun-Mi Cho (2017)
10.1016/j.lfs.2020.117908
Empagliflozin ameliorates ethanol-induced liver injury by modulating NF-κB/Nrf-2/PPAR-γ interplay in mice.
Amir Mohamed Abdelhamid (2020)
Antioxidant activity and hepatoprotective effect of 10 medicinal herbs on CCl4-induced liver injury in mice
X. Meng (2020)
10.1007/s12199-016-0579-2
Roles of defective ALDH2 polymorphism on liver protection and cancer development
A. Matsumoto (2016)
10.1053/j.gastro.2017.09.022
MicroRNA 122, Regulated by GRLH2, Protects Livers of Mice and Patients From Ethanol-Induced Liver Disease.
A. Satishchandran (2018)
10.1039/C8RA02422G
Correction: Patchouli oil isolated from the leaves of Pogostemon cablin ameliorates ethanol-induced acute liver injury in rats via inhibition of oxidative stress and lipid accumulation
Qiong-hui Huang (2018)
10.1016/j.jconrel.2019.12.018
Attenuation of neutrophil-mediated liver injury in mice by drug-free E-Selectin binding polymer.
Nenad Milošević (2019)
10.1016/s1875-5364(20)30020-0
Berbamine ameliorates ethanol-induced liver injury by inhibition of hepatic inflammation in mice.
Xin-yu Liu (2020)
10.1016/j.jhep.2019.08.019
Transient elastography for screening of liver fibrosis: cost-effectiveness analysis from six prospective cohorts in Europe and Asia.
M. Serra-Burriel (2019)
10.1016/j.alcohol.2018.07.009
Good outcome of living donor liver transplantation for severe alcoholic hepatitis not responding to medical management: A single center experience of 39 patients.
Narendra Singh Choudhary (2019)
10.3168/jds.2019-17247
Camel milk modulates ethanol-induced changes in the gut microbiome and transcriptome in a mouse model of acute alcoholic liver disease.
L. Ming (2020)
10.22146/JCOEMPH.38574
Karakteristik performance individu muda di Desa Ngablak dan hubungannya dengan penyalahgunaan NAPZA
S. Suhartini (2019)
10.3390/ijms17010030
EGFR Signaling in Liver Diseases
Karin Komposch (2015)
10.3389/fphar.2018.00081
Alcohol-Mediated Organ Damages: Heart and Brain
Adam S Obad (2018)
10.3389/fphys.2020.00369
Dietary Copper Plays an Important Role in Maintaining Intestinal Barrier Integrity During Alcohol-Induced Liver Disease Through Regulation of the Intestinal HIF-1α Signaling Pathway and Oxidative Stress
Hongwei Lin (2020)
10.1007/s00109-019-01808-7
S100A4 promotes inflammation but suppresses lipid accumulation via the STAT3 pathway in chronic ethanol-induced fatty liver
Qi Yuan (2019)
10.1055/s-0038-1629924
The Receptor Interacting Protein Kinases in the Liver.
L. Dara (2018)
10.1055/a-0757-0008
Fighting Liver Fibrosis with Naturally Occurring Antioxidants.
Ligen Lin (2018)
10.3390/ijms160922062
Inhibition of Hepatocyte Apoptosis: An Important Mechanism of Corn Peptides Attenuating Liver Injury Induced by Ethanol
Zhili Ma (2015)
10.1016/j.ceb.2017.06.002
Metastasis 'systems' biology: how are macro-environmental signals transmitted into microenvironmental cues for disseminated tumor cells?
C. A. Grzelak (2017)
10.1007/164_2017_88
Hepatic Immune System: Adaptations to Alcohol.
Adam Kim (2018)
10.1016/j.tox.2017.05.014
B-13 progenitor-derived hepatocytes (B-13/H cells) model lipid dysregulation in response to drugs and chemicals
Alistair C. Leitch (2017)
10.1053/j.gastro.2016.02.042
Standard Definitions and Common Data Elements for Clinical Trials in Patients With Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis Consortia.
D. Crabb (2016)
10.1038/srep18685
Telomerase reverse transcriptase acts in a feedback loop with NF-κB pathway to regulate macrophage polarization in alcoholic liver disease
X. Wu (2016)
10.3748/wjg.v26.i24.3432
Hepatoprotective effects of Hovenia dulcis seeds against alcoholic liver injury and related mechanisms investigated via network pharmacology
Xiao Meng (2020)
10.1139/bcb-2016-0142
Diosmin attenuates radiation-induced hepatic fibrosis by boosting PPAR-γ expression and hampering miR-17-5p-activated canonical Wnt-β-catenin signaling.
Hesham Farouk Hasan (2017)
See more
Semantic Scholar Logo Some data provided by SemanticScholar